← All diseases

Disease Atlas / Disease detail

Giant axonal neuropathy

Educational material for understanding the causes, changing symptoms, diagnosis, management, and research directions of giant axonal neuropathy.

giant axonal neuropathy

MONDO:0000128Public QA completeSource-bound · 1

Disease at a glance

Start with the essentials, then explore the patient and research views.

Public revision · 5a0880f51a77

Disease category
Giant axonal neuropathy is a rare inherited neurodegenerative disorder in which the peripheral nerves and central nervous system are progressively damaged.
Core mechanism
It is usually an autosomal recessive disorder associated with variants in both copies of the GAN gene.
Main causes and associated factors
Abnormal gigaxonin function can disrupt the handling of intermediate filament proteins within cells, impairing neuronal function and axonal structure.
Typical manifestations
Typical features include progressive weakness beginning early in life, sensory abnormalities, reduced reflexes, and problems with gait and balance.
Individual variation
Age at onset and rate of progression can vary among families and individuals, and the degree of central nervous system and sensory-organ involvement can differ even within the same genetic disorder.
Diagnosis
Over time, muscle wasting and loss of mobility may progress, and tightly curled or coarse hair, optic nerve abnormalities, cognitive or behavioral changes, seizures, or autonomic symptoms may also occur.
Management
Diagnosis integrates age at onset, family history, hair characteristics, and neurological findings and is confirmed primarily through GAN genetic testing.
Treatment and research status
Genetic test results must be reviewed together with variant pathogenicity, test coverage, family testing, and clinical findings; a single test may not explain every symptom.
Reading the evidence
Management uses a multidisciplinary approach led by neurology to coordinate rehabilitation, physical and occupational therapy, orthoses, nutrition, breathing and swallowing care, vision and hearing assessment, and seizure evaluation.
Key caution
A standard treatment that directly corrects the cause of the disorder has not been established, and care aims to preserve function and prevent complications.

For patients and families

A structured guide for understanding the disease and preparing for clinical conversations.

At a glance

Giant axonal neuropathy is a rare inherited neurodegenerative disorder in which the peripheral nerves and central nervous system are progressively damaged.

Typical features include progressive weakness beginning early in life, sensory abnormalities, reduced reflexes, and problems with gait and balance.

How the disorder works

It is usually an autosomal recessive disorder associated with variants in both copies of the GAN gene.

Abnormal gigaxonin function can disrupt the handling of intermediate filament proteins within cells, impairing neuronal function and axonal structure.

How it varies from person to person

Age at onset and rate of progression can vary among families and individuals, and the degree of central nervous system and sensory-organ involvement can differ even within the same genetic disorder.

Overall approach to diagnosis and management

Over time, muscle wasting and loss of mobility may progress, and tightly curled or coarse hair, optic nerve abnormalities, cognitive or behavioral changes, seizures, or autonomic symptoms may also occur.

Diagnosis integrates age at onset, family history, hair characteristics, and neurological findings and is confirmed primarily through GAN genetic testing.

Current state of treatment

Genetic test results must be reviewed together with variant pathogenicity, test coverage, family testing, and clinical findings; a single test may not explain every symptom.

Management uses a multidisciplinary approach led by neurology to coordinate rehabilitation, physical and occupational therapy, orthoses, nutrition, breathing and swallowing care, vision and hearing assessment, and seizure evaluation.

A standard treatment that directly corrects the cause of the disorder has not been established, and care aims to preserve function and prevent complications.

How to read clinical trials

Regular follow-up should assess changes in motor and sensory function, gait, breathing and swallowing, vision and hearing, nutritional status, and daily functioning.

Points to discuss during a clinical visit

During a clinical visit, it is useful to review the first symptoms and rate of change, family history, the genetic test report, gait, sensory, visual, auditory, respiratory, and swallowing function, and current rehabilitation and support needs.

Medical information

This material is for educational purposes and does not replace individualized diagnostic or treatment guidance.

Evidence and sources

A trial registry status does not establish efficacy or regulatory approval.